News & Updates
Filter by Specialty:
Dextromethorphan-bupropion relieves symptoms in major depressive disorder
Treatment with dextromethorphan-bupropion (AXS-05) significantly improves depressive symptoms relative to bupropion alone and is well tolerated in patients with major depression, results of a phase II trial have shown.
Dextromethorphan-bupropion relieves symptoms in major depressive disorder
13 Jul 2022Ventral striatum connectivity may predict depression in adolescence
The connectivity strength of the ventral striatum (VS) within the reward network demonstrates links to depressive disorders and anhedonia from mid to late adolescence, which indicates the role played by this circuitry in depression changes with age, reveals a study.
Ventral striatum connectivity may predict depression in adolescence
12 Jul 2022Clinical anxiety common in children with autism spectrum disorders
Children with autism spectrum disorders (ASD) are highly likely to suffer from clinical-level anxiety, a recent study has found. ASD severity and sensory processing difficulties appear to aggravate anxiety in this population.
Clinical anxiety common in children with autism spectrum disorders
11 Jul 2022Isotretinoin does not hurt patients’ mental health, study says
While treatment with isotretinoin for acne is said to have a negative impact on mental health, its use appears to instead mitigate the excess psychiatric risk associated with treatment-resistant moderate-to-severe acne, as reported in a large study.
Isotretinoin does not hurt patients’ mental health, study says
11 Jul 2022Full lockdown hurts teens’ mental health
A recent Dutch study has found that mental wellbeing in adolescents deteriorate during the full lockdowns to curb the COVID-19 outbreak, though such strict restrictions also seem to confer some degree of psychological benefit.
Full lockdown hurts teens’ mental health
07 Jul 2022Poor mental health tied to worse prognosis, outcomes in IBD
Psychological problems, such as anxiety or depression, can negatively affect prognosis and eventual outcomes in patients with inflammatory bowel diseases (IBD), according to a recent study.